Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Blarcamesine hydrochloride by Anavex Life Sciences for Fragile X Syndrome: Likelihood of Approval
Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Fragile X Syndrome. According...
Blarcamesine hydrochloride by Anavex Life Sciences for Infantile Spasm (West Syndrome): Likelihood of Approval
Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Infantile Spasm (West Syndrome)....
Blarcamesine hydrochloride by Anavex Life Sciences for Angelman Syndrome: Likelihood of Approval
Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Angelman Syndrome. According to...